What is NDC 71335-1730?

71335-1730 is the product NDC for Carbamazepine, Carbamazepine 200 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carbamazepine?

133 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carbamazepine NDC 71335-1730 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-1730Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-1730Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-1730-1	7133517300171335173001	30 TABLET in 1 BOTTLE (71335-1730-1)Marketed from Nov 9, 2020
71335-1730-2	7133517300271335173002	60 TABLET in 1 BOTTLE (71335-1730-2)Marketed from Jul 8, 2021
71335-1730-3	7133517300371335173003	90 TABLET in 1 BOTTLE (71335-1730-3)Marketed from Oct 5, 2021
71335-1730-4	7133517300471335173004	120 TABLET in 1 BOTTLE (71335-1730-4)Marketed from Jan 30, 2025
71335-1730-5	7133517300571335173005	240 TABLET in 1 BOTTLE (71335-1730-5)Marketed from Jan 30, 2025
71335-1730-6	7133517300671335173006	180 TABLET in 1 BOTTLE (71335-1730-6)Marketed from Jan 30, 2025
71335-1730-7	7133517300771335173007	100 TABLET in 1 BOTTLE (71335-1730-7)Marketed from Jan 30, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carbamazepine
Generic name (nonproprietary): carbamazepine
Active ingredients: Carbamazepine — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207798
Marketing start: Apr 21, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 71335-1730_83bf35ae-914c-4e7d-8f2b-73cb3ecef8faSPL ID 83bf35ae-914c-4e7d-8f2b-73cb3ecef8faSPL set ID 62d38b93-7dd0-48e7-bd59-a434d52520f6RxCUI 308979UNII 33CM23913M
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335173001 followed by a unit qualifier and the quantity

Package 71335-1730-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 14, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1. Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. 2. Generalized tonic-clonic seizures (grand mal). 3. Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS , General). Trigeminal Neur…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-1730

What is NDC 71335-1730?: 71335-1730 is the product NDC for Carbamazepine, Carbamazepine 200 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carbamazepine.
What is the active ingredient?: Carbamazepine.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carbamazepine?: 133 other product NDCs are listed under this name. See all Carbamazepine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carbamazepine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carbamazepine	Carbamazepine 100 mg/5mL	SuspensionOral	Precision Dose, Inc.	68094-125	68094-0125-62
Carbamazepine	Carbamazepine 100 mg/5mL	SuspensionOral	Precision Dose, Inc.	68094-225	68094-0225-62
Carbamazepine	Carbamazepine 100 mg/1	Tablet, Extended releaseOral	American Health Packaging	60687-973	60687-0973-21
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	REMEDYREPACK INC.	70518-4682	70518-4682-00
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Coupler LLC	67046-0753	67046-0753-03
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Coupler LLC	67046-0707	67046-0707-03
Carbamazepine	Carbamazepine 100 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-484	62559-0484-12
Carbamazepine	Carbamazepine 200 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-485	62559-0485-12
Carbamazepine	Carbamazepine 300 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-486	62559-0486-12
Carbamazepine	Carbamazepine 200 mg/1	Tablet, Extended releaseOral	Northstar Rx LLC	72603-887	72603-0887-01

All 134 Carbamazepine NDCs

Other NDCs under ANDA 207798

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207798
Product	Strength	Form · route	Labeler	Product NDC
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	A-S Medication Solutions	50090-5740
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-008
Carbamazepine	Carbamazepine 100 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-034
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Coupler LLC	67046-0707
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-7825
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	REMEDYREPACK INC.	70518-2841
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	direct rx	72189-157
Carbamazepine	Carbamazepine 100 mg/1	TabletOral	NIVAGEN PHARMACEUTICALS, INC.	75834-220
Carbamazepine	Carbamazepine 200 mg/1	TabletOral	NIVAGEN PHARMACEUTICALS, INC.	75834-221